HIV/AIDS
Featured Article
Payments for HIV PrEP medication in the United States totaled more than $2.08 billion in 2018, according to a Centers for Disease Control and Prevention study recently published in Annals of Internal Medicine.
“The relatively recent phenomenon of co-existence and clustering of chronic communicable conditions, such as HIV, with highly-prevalent noncommunicable diseases, represents a serious threat for a…
Ed Pezalla, MD, CEO, Enlightenment Bioconsult LLC, speaks about the barriers to preventive HIV care, pinpoints how payers can reach at-risk populations, and reviews the US Preventive Services Task…